Showing 1 - 6 results of 6 for search 'Mario Alberto Ynga-Durand', query time: 0.03s Refine Results
  1. 1
    Vaccine Vectors Harnessing the Power of Cytomegaloviruses

    Vaccine Vectors Harnessing the Power of Cytomegaloviruses by Mario Alberto Ynga-Durand, Iryna Dekhtiarenko, Luka Cicin-Sain

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigen

    Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigen by Fawad Khan, Fawad Khan, Fawad Khan, Thomas R. Müller, Thomas R. Müller, Bahram Kasmapour, Bahram Kasmapour, Mario Alberto Ynga-Durand, Mario Alberto Ynga-Durand, Britta Eiz-Vesper, Jens von Einem, Dirk H. Busch, Dirk H. Busch, Luka Cicin-Sain, Luka Cicin-Sain, Luka Cicin-Sain

    Published 2024-07-01
    Get full text
    Article
  3. 3
    Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome

    Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome by Cesar Daniel Alonso-Bello, María del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, Mario Alberto Ynga-Durand, Laura Berrón-Ruiz, Julio César Alcántara-Montiel, Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sánchez, Fernando Lozano-Patiño, María Isabel Castrejón-Vázquez

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”

    Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” by Cesar Daniel Alonso-Bello, María del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, Mario Alberto Ynga-Durand, Laura Berrón-Ruiz, Julio César Alcántara-Montiel, Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sánchez, Fernando Lozano-Patiño, María Isabel Castrejón-Vázquez

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

    Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant by Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Henrike Maass, Josè Camilla Sammartino, Irene Cassaniti, Fanglei Zuo, Likun Du, Janin Korn, Marko Milošević, Esther Veronika Wenzel, Fran Krstanović, Saskia Polten, Marina Pribanić-Matešić, Ilija Brizić, Fausto Baldanti, Lennart Hammarström, Stefan Dübel, Alan Šustić, Harold Marcotte, Monika Strengert, Alen Protić, Antonio Piralla, Qiang Pan-Hammarström, Luka Čičin-Šain, Michael Hust

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations

    Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations by Henning Jacobsen, Monika Strengert, Henrike Maaß, Mario Alberto Ynga Durand, Maeva Katzmarzyk, Barbora Kessel, Manuela Harries, Ulfert Rand, Leila Abassi, Yeonsu Kim, Tatjana Lüddecke, Kristin Metzdorf, Pilar Hernandez, Julia Ortmann, Jana-Kristin Heise, Stefanie Castell, Daniela Gornyk, Stephan Glöckner, Vanessa Melhorn, Yvonne Kemmling, Berit Lange, Alex Dulovic, Patrick Marsall, Julia Häring, Daniel Junker, Nicole Schneiderhan-Marra, Markus Hoffmann, Stefan Pöhlmann, Gérard Krause, Luka Cicin-Sain

    Published 2022-11-01
    Get full text
    Article

Search Tools: